GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway
Journal of Hepatocellular Carcinoma · 2026-05 · Volume 13 · 1-15
DOI: 10.2147/jhc.s581550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2026-05. Verfasst von Jiaqian He und 10 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, People's Republic of China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, People's Republic of China.
- Guangxi Key Laboratory of Molecular Biology of Preventive Medicine of Traditional Chinese Medicine, Nanning, People's Republic of China.
- Laboratory Department, Liuzhou Traditional Chinese Medical Hospital, Liuzhou, People's Republic of China.
- Laboratory Department, First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, People's Republic of China.
ORCID-Profile: Hongsheng Lin, Mingfen Li
Zitieren
APA
He, J., Kong, Y., Wang, Y., Fang, Q., Wu, H., Du, K., Luo, Y., Tan, J., Yin, H., Lin, H., & Li, M. (2026). GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway. Journal of Hepatocellular Carcinoma, Volume 13, 1-15. https://doi.org/10.2147/jhc.s581550
Vancouver
He J, Kong Y, Wang Y, Fang Q, Wu H, Du K, et al. GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway. Journal of Hepatocellular Carcinoma. 2026;Volume 13:1-15. doi:10.2147/jhc.s581550
BibTeX
@article{He2026,
author = {He, Jiaqian and Kong, Yinzhi and Wang, Yunyong and Fang, Qiaoling and Wu, Hemeng and Du, Kewei and Luo, Yuzhen and Tan, Jinna and Yin, Hui and Lin, Hongsheng and Li, Mingfen},
title = {GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway},
journal = {Journal of Hepatocellular Carcinoma},
year = {2026},
volume = {Volume 13},
pages = {1--15},
doi = {10.2147/jhc.s581550}
}
EUVIMED